AIDS Related Lymphoma
Aggressive lymphomas can occur in patients who are human Immunodeficiency virus (HIV) positive. It is estimated that 10 percent of HIV positive patients will develop lymphoma.
The lymphomas that most often seen in HIV patients who develop them are:
- Large Cell Immunoblastic
- Burkitt's Lymphoma
- Primary Central Nervous System
- Hodgkin's Lymphoma (Disease)
National Cancer Institute Information Sheet
- AIDS Related Cancer main page
- An NCI article on a 2003 article in the Journal Blood suggest the use of HAART in AIDS treatment has caused a shift in AIDS related lymphomas to a type that responds well to chemotherapy
News - April 2000:
CHICAGO (AP) - Hodgkin's disease and possibly two other types of cancer should be added to the list of illnesses used to determine whether HIV-infected patients have full-blown AIDS, new research suggests.
The study examined more than 300,000 AIDS patients and their rates of several types of malignancies other than cancers already linked to the disease.
AIDS patients were more than 11 times more likely to have Hodgkin's disease, three times more likely to have lip cancer and about twice as likely to have a form of testicular cancer, the researchers reported in Wednesday's Journal of the American Medical Association.
In determining whether HIV-positive patients have developed full-blown AIDS, doctors consider whether they have cancers known to occur when the AIDS virus has damaged the body's disease-fighting immune system.
The cancers already considered AIDS-defining diseases are cervical cancer, non-Hodgkin's lymphoma and a form of skin cancer known as Kaposi's sarcoma.
The study was led by Dr. Morten Frisch from both the National Cancer Institute and the Danish Epidemiology Science Center.
Resources
HIV Lymphoma Papers and Abstracts from the Medical Advocates for Social Justice - a large collection
A Perspective on AIDS Lymphoma from AEGIS and Being Alive
JAMA HIV/AIDS Information Center
Non-Hodgkin's and HIV from Project Inform
AZT and Lymphoma from the AIDS Treatment News archive
Clinical Trial Information & NCI AIDS Related Trials
HIV InSite: http://hivinsite.ucsf.edu
Patient Perspectives:
The Body has a long list of Lymphoma Questions & Answers
HIV and Hodgkin's sample question
Related Articles
For more information on Adult Non-Hodgkin's Lymphoma Pages:
Non-Hodgkin's Lymphoma: Diagnosis
Non-Hodgkin's Lymphoma: Aggressive Lymphomas
Non-Hodgkin's Lymphoma: Indolent Lymphomas
Non-Hodgkin's Lymphoma: Treatment
Non-Hodgkin's Lymphoma: Resources
Bone Marrow and Stem Cell Transplants
Adult Hodgkin's Information Pages:
Also of interest:
Childhood Non-Hodgkin's Lymphoma Information Pages
The Lymphoma Information Network
Books
Non-Hodgkin's Lymphomas, Peter M. Mauch (Editor), James O. Armitage (Editor), et al., 2004.
Section VI: Special Topics
Chapter 39: Management of Acquired Immunodeficiency Syndrome-Related Lymphoma
Excellent but Technical: An Illustrated Guide to Skin Lymphomas, Cerroni, Gatter, Kerl, 2nd. Ed, 2005
• Chapter 19: Cutaneous Lymphomas in Immunosuppressed Individuals, pp 151-154
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
